Depression

What are the biggest challenges facing both clinicians and patients, and how can we address them?

A psychiatrist lists the top 8 most pressing issues in MDD, from training to accessibility.

Adjunctive metformin in bipolar disorder. Researchers performed a randomized clinical trial of treating insulin resistance to improve clinical outcomes in treatment-resistant bipolar depression.

Zuranolone, an investigational oral drug being evaluated in women with postpartum depression, sees positive phase 3 study results.

Axsome Therapeutics announced the robust antidepressant efficacy demonstrated in this latest study.

Here’s why we should be paying special attention to women's depression treatment.

Recommendations are often vague, contradictory, according to investigators.

Home environments have a clear impact on depression treatment outcomes.

In this CME, review novel, currently available, and promising pharmacological treatment options for treatment-resistant depression.

Zuranolone, a drug for the treatment of major depressive disorder and postpartum disorder, is on a rolling submission of a new drug application.

The experts weighed in on a wide variety of psychiatric issues for the April 2022 issue of Psychiatric Times.

The most common issues during the COVID-19 pandemic included stress, anxiety.

Sidney Zisook, MD, lists these as the top 8 issues in MDD.

Catch up on all the latest from the American Pharmacists Association (APhA) Annual Meeting & Exposition.

Evidence review focuses on bipolar disorder, psychosis, and major depression.

In this CME, evaluate the treatment options for depression among older adults.

Study supports evidence for long-term impairment in memory, executive function.

Individuals with depression may be at a greater risk to develop late-onset Alzheimer disease, but a new study suggests depression onset may help predict Alzheimer disease.

ECT played an important role in this patient's journey to recovery.

Patients with bipolar I disorder and other mental illnesses may be at increased risk for COVID-19 infection.

According to this study examining sexual minority patients, depression can be a consequence of health and behavioral disparities.

Learn what potential challenges come with mHealth apps and how to overcome them to best fit patient needs.

How can these mHealth apps help in the treatment of depression?

How can mHealth apps help overcome barriers to access to care?

In this CME article, learn about the best ways to assess depression in the geriatric population.